The role of genetic testing in paediatric syndromes of sudden death: State of the art and future considerations

Cardiology in the Young

Volumn 19, Issue SUPPL.2, 2009, Pages 54-65

  McCormack, Jorge ^a  

^a PEDIATRIX MEDICAL GROUP   (United States)

Author keywords

Arrhythmia; Electrophysiology; Genetics; Paediatric cardiology

Indexed keywords

ALPHA ACTIN; ALPHA TROPOMYOSIN; AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAVEOLIN 3; DESMOGLEIN 2; DESMOPLAKIN; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.1; METOPROLOL; MEXILETINE; MYOSIN BINDING PROTEIN C; MYOSIN HEAVY CHAIN BETA; MYOSIN LIGHT CHAIN 2; NADOLOL; PLAKOPHILIN; POTASSIUM CHANNEL KCNE1; POTASSIUM CHANNEL KCNE2; POTASSIUM CHANNEL KCNQ1; RYANODINE RECEPTOR 2; TROPONIN C; TROPONIN I; TROPONIN T;

AUTOPSY; AUTOSOMAL DOMINANT INHERITANCE; BRUGADA SYNDROME; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CONFERENCE PAPER; DEFIBRILLATOR; DESMOSOME; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; ELECTROCARDIOGRAPHY; GENE MUTATION; GENETIC ANALYSIS; GENETIC SCREENING; HEART RIGHT VENTRICLE DYSPLASIA; HISTOPATHOLOGY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INCIDENCE; LONG QT SYNDROME; MUTATIONAL ANALYSIS; PEDIATRIC CARDIOLOGY; PREVALENCE; SUDDEN DEATH; SUDDEN INFANT DEATH SYNDROME;

ADOLESCENT; BRUGADA SYNDROME; CARDIOMYOPATHY, HYPERTROPHIC; CHILD; CHILD, PRESCHOOL; DEATH, SUDDEN; DIAGNOSIS, DIFFERENTIAL; GENETIC TESTING; HEART DISEASES; HUMANS; INFANT; INFANT, NEWBORN; LONG QT SYNDROME; SUDDEN INFANT DEATH; TACHYCARDIA, VENTRICULAR;

EID: 76449116701     PISSN: 10479511     EISSN: 14671107     Source Type: Journal    
DOI: 10.1017/S1047951109991636     Document Type: Conference Paper

References (61)

1. Maron BJ, Shirani J, Poliac LC, Mathenge R, Roberts WC, Mueller FO. Sudden death in young competitive athletes. Clinical, demographic, and pathologic profiles. JAMA 1996; 276: 199-204.
2. Tabib A, Mirast A, Taniere P, Loire RA. Undetected cardiac lesions cause unexpected sudden cardiac death during occasional sport activity: A report of 80 cases. European Heart Journal 1999; 20: 900-903.
3. Corrado D, Basso C, Schiavon M, Thiene G. Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med 1998; 3396: 364-369.
4. Suarez-Mier MP, Aguilera B. Trends in mortality due to cardiovascular diseases in Andalusia, Spain. Rev. Esp Cardiol 2002; 554: 347-438.
5. Kahali B, Roy DG, Batabyal S, Bose TK. Study of sudden cardiac deaths in young athletes. J Indian Med Assoc 2002; 100 (12): 708-709.
6. Maron BJ. Sudden death in young athletes. N Engl J Med 2003; 349 (11): 1064-1075.
7. Berger S, Dhala A, Friedberg DZ. Sudden cardiac deaths in infants, children and adolescents. Pediatric Clin North Am 1999; 46 (2): 221-234.
8. Neuspiel DR, Kuller LH. Sudden and unexpected natural death in childhood and adolescence. JAMA 1985; 254 (10): 1321-1325.
9. Keren A, Syrris P, McKenna WJ. Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression. Nat Clin Pract Cardiovasc Med 2008; 5 (3): 158-168.
10. Baron MJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: Echocardiographic analysis of 4111 subjects in the CARDIA Study. Circulation 1995; 92 (4): 785-789.
11. Van Driest SL, Ommen SR, Tajik AJ, Gersh BJ, Ackerman MJ. Sarcomeric genotyping in hypertrophic cardiomyopathy. Mayo Clin Proc 2005; 80 (4): 463-469.
12. Geisterfer-Lowrance AA, Kass S, Tanigawa G. A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation. Cell 1990; 62 (5): 999-1006.
13. Watkins H, Rosenzweig A, Hwang DS, et al. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med 1992; 326 (17): 1108-1114.
14. Van Driest SL, Vasile VC, Ommen SR, et al. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy. J Am Coll Cardiol 2004; 44 (9): 1903-1910.
15. Van Driest SL, Ommen SR, Tajik AJ, Gersh BJ, Ackerman MJ. Sarcomeric genotyping in hypertrophic cardiomyopathy. Mayo Clin Proc 2005; 80 (4): 463-469.
16. Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy. N Engl J Med 1997; 336 (11): 775-785.
17. Solomon SD, Wolff S, Watkins H. Left ventricular hypertrophy and morphology in familial hypertrophic cardiomyopathy associated with mutations of the beta-myosin heavy chain gene. J Am Coll Cardiol 1993; 22 (2): 498-505.
18. Binder J, Ommen SR, Gersh BJ, et al. Echocardiography-guided testing in hypertrophic cardiomyopathy: septal morphological features predict the presence of myofilament mutations. Mayo Clin Proc 2006; 81 (4): 459-467.
19. ACC/AHA/ECC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death-executive summary. A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. European Heart Journal 2007; 27 (17): 2099-2140.
20. Nava A, Thiene G, Canciani B, et al. Familial occurrence of right ventricular dysplasia: a study involving nine families. J Am Coll Cardiol 1988; 12 (5): 1222-1228.
21. Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 1996; 93 (5): 841-842.
22. Sen-Chowdhry S, Syrris P, McKenna WJ. Role of genetic analysis in the management of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. JACC 2007; 50 (19): 1813-1821.
23. Corrado D, Thiene G. Arrythmogenic right ventricular cardiomyopathy/ dysplasia: clinical impact of molecular genetic studies. Circulation 2006; 113 (13): 1634-1637.
24. Priori SG, Bloise R, Crotti L. The long QT syndrome. Europace 2001; 3 (1): 16-27.
25. Jervell A, Lange-Nielsen F. Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death. Am Heart J 1957; 54 (1): 59-68.
26. Romano C, Gemme G, Pongiglione R. Aritmie cardiache rare in eta pediatrica. ClinPed 1963; 45: 656-683.
27. Ward OC. A new familial cardiac syndrome in children. J Ir Med Assoc 1964; 54: 103-106.
28. Bazett HC. An analysis of the time-relations of electrocardiograms. Heart 1920; 7: 353-370.
29. Taggart NW, Haglund CM, Tester DJ, Ackerman MJ. Diagnostic miscues in congenital long QT syndrome. Circulation 2007; 115 (20): 2613-2620.
30. Schwartz PJ, Moss AJ, Vincent GM, Crampton RS. Diagnostic criteria for the long QT syndrome. An update. Circulation 1993; 88 (2): 782-784.
31. Moss AJ, Scwartz PJ. 25th anniversary of the International long QT syndrome Registry: an ongoing quest to uncover the secrets of long QT syndrome. Circulation 2005; 111 (9): 1199-1201.
32. Keating M, Atkinson D, Dunn C, Timothy K, Vincent GM, Leppert M. Linkage of a cardiac arrhythmia, the long QT syndrome, and the Harvey Ras-1 gene. Science 1991; 252 (5006): 704-706.
33. Dumaine R, Wang Q, Keating MT, Hartmann HA, Schwartz PJ, Brown AM, Kirsch GE. Multiple mechanisms of Na1 channel-linked long QT syndrome. Circulation Research 1996; 78 (5): 916-924.
34. Bennett PB, Yazawa K, Makita N, George AL Jr. Molecular mechanism for an inherited cardiac arrhythmia. Nature 1995; 376 (6542): 683-685.
35. Priori SG, Napolitano C, Schwartz PJ. Low penetrance in the long QT syndrome. clinical impact. Circulation 1999; 99 (4): 529-533.
36. Moss AJ, Zareba W, Benhorin J, et al. ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation 1995; 92 (10): 2929-2934.
37. Etheridge SP, Sanatani S, Cohen MI, Albaro CA, Saarel EV, Bradley DJ. Long QT syndrome in children in the era of implantable defibrillators. J Am Coll Cardiol 2007; 50 (14): 1335-1340.
38. Tester DJ, McCormack J, Ackerman MJ. Prenatal molecular genetic diagnosis of congenital long QT syndrome by strategic genotyping. Am J Cardiol 2004; 93 (6): 788-791.
39. Phillips KA, Ackerman MJ, Sakowski J, Berul CI. Costeffectiveness analysis of genetic testing for familial long QT syndrome in symptomatic index cases. Heart Rhythm 2005; 2 (12): 1294-1300.
40. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 1992; 20 (6): 1391-1396.
41. Corrado D, Nava A, Buja G, et al. Familial cardiomyopathy underlies syndrome of right bundle branch block, ST segment elevation and sudden death. J Am Coll Cardiol 1996; 27 (2): 443-448. (Pubitemid 26045511)
42. Chen Q, Kirsch GE, Zhang D, et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 1998; 392 (6673): 293-296.
43. Priori SG, Napolitano C, Gasparini M, et al. Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome: A prospective evaluation of 52 families. Circulation 2000; 102 (20): 2509-2515.
44. Priori SG, Napolitano C, Gasparini M, et al. Natural history of Brugada syndrome: insights for risk stratification and management. Circulation 2002; 105 (11): 1342-1347. (Pubitemid 34260426)
45. Antzelevitch C, Brugada P, Borggrefe M, et al. Brugada syndrome: report of the second consensus conference. Heart Rhythm 2005; 2 (4): 429-440. (Pubitemid 40439292)
46. Beaufort-Krol GC, Van Den Berg MP, Wilde AA, et al. Developmental aspects of long QT syndrome type 3 and Brugada syndrome on the basis of a single SCN5A mutation in childhood. J Am Coll Cardiol 2005; 46 (2): 331-337.
47. Probst V, Denjoy I, Meregalli PG, et al. Clinical aspects and prognosis of Brugada syndrome in children. Circulation 2007; 115 (15): 2042-2048.
48. Skinner JR, Chung SK, Nel CA, et al. Brugada syndrome masquerading as febrile Seizures. Pediatrics 2007; 119 (5): e1206-e1211.
49. Priori SG, Napolitano C, Tiso N, et al. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 2001; 103 (2): 196-200. (Pubitemid 32095402)
50. Priori SG, Napolitano C. Cardiac and skeletal muscle disorders caused by mutations in the intracellular Ca21 release channels. J Clin Invest 2005; 115 (8): 2033-2038.
51. Napolitano C, Priori SG. Diagnosis and treatment of catecholaminergic polymorphic ventricualar tachycardia. Heart Rhythm 2007; 4 (5): 675-678. (Pubitemid 46655581)
52. Sumitomo N, Harada K, Nagashima M, et al. Catecholaminergic polymorphic ventricualar tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death. Heart 2003; 89 (1): 66-70.
53. American Academy of Pediatrics AAP Task Force on Infant Positioning and SIDS. Positioning and SIDS. Pediatrics 1992; 89 (6 Pt 1): 1120-1126.
54. Blair PS, Sidebotham P, Berry PJ, Evans M, Fleming PJ. Major epidemiological changes in sudden infant death syndrome: a 20-year population-based study in the UK. Lancet 2006; 367 (9507): 314-319.
55. Maron BJ, Clark CE, Glodstein RE, Epstein SE. Potential role of QT interval prolongation in sudden infant death syndrome. Circulation 1976; 54 (3): 423-430.
56. Schwartz PJ, Stramba-Badiale M, Segantini A, et al. Prolongation of the QT interval and the sudden infant death syndrome. NEJM 1998; 338 (24): 1709-1714.
57. Skinner JR, Chung SK, Montgomery D, et al. Near-miss SIDS due to Brugada syndrome. Arch Dis Child 2005; 90 (5): 528-529.
58. Arnestad M, Crotti L, Rognum TO, et al. Prevalence of long QT syndrome gene variants in sudden infant death syndrome. Circulation 2007; 115 (3): 361-367. (Pubitemid 46148510)
59. Cronk L, Ye B, Tester D, Vatta M, Makielski J, Ackerman MJ . AB32-3 Identification of CAV3-encoded caveolin-3 mutations in sudden infant death syndrome. Heart Rhythm Vol3, Issue 5, Pages S66-S67.
60. Tester D, Carturan E, Dura M , et al. AB32-4 Molecular and functional characterization of novel RyR2-encoded cardiac ryanodine receptor/calcium release channel mutations in sudden infant death syndrome. Heart Rhythm Vol3, Issue 5, Pages S67-S67.
61. Tester DJ, Ackerman MJ. Postmortem long QT syndrome genetic testing for sudden unexplained death in the young. J Am Coll Cardiol 2007; 49 (2): 240-246.